prostamax
TETRAPEPTIDE · KHAVINSON PROSTATE BIOREGULATOR · KEDP · NO HUMAN OUTCOME DATA
also: KEDP · Lys-Glu-Asp-Pro · Простамакс
Prostamax is the prostate-directed member of the Khavinson series and, unusually for the family, is unambiguously identified: PubChem lists it by name as Lys-Glu-Asp-Pro with a CAS number. Its published work is confined to chromatin decondensation and microcalorimetry in cultured human lymphocytes, plus one organotypic tissue-culture screen. There is no clinical trial, no human outcome study, and no prostate-tissue functional experiment in the retrievable literature.
// our evidence grade — unedited
Prostamax has a fully verified structure but not one human clinical outcome study of any design: its six PubMed-indexed papers are chromatin and calorimetry experiments on cells, and ClinicalTrials.gov returns zero registered studies — while the clinical results the market attributes to it actually belong to Prostatilen, a different prostate preparation.
We grade this compound and we sell it. The grade is set against our published criteria before any stocking decision and is not adjusted because it is in the catalogue.
read the full evidence →// specification
| full name | Prostamax (Lys-Glu-Asp-Pro; KEDP tetrapeptide) |
| cas | 473578-47-1 |
| formula | C20H33N5O9 |
| molar mass | 487.5 g/mol |
| purity | ≥ 98% HPLC |
| form | lyophilised powder, sealed vial |
| storage | Lyophilised powder is stored desiccated at -20 °C and protected from light. Once reconstituted, laboratory practice is refrigeration at 2-8 °C for short-term use, or aliquoting and freezing to avoid repeated freeze-thaw cycles. Handling information only; this material has no approved human use. |
| solubility | Short hydrophilic peptide, readily soluble in sterile or bacteriostatic water and in dilute aqueous buffer. Lot-specific solubility is stated on the certificate of analysis. |
| sequence | Lys-Glu-Asp-Pro (KEDP) |
// select size
crypto payment · research use only · not for human consumption
// others in Other